COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,557 Articles (22,400 medRxiv, 8,157 bioRxiv)

Most recent first Previous |  Page 1203: Articles 12021-12030  | Next

The resurgence risk of COVID-19 in the presence of immunity waning and ADE effect: a mathematical modelling study
Zhou, W., Tang, B., Bai, Y., Shao, Y., Xiao, Y., Tang, S.
10.1101/2021.08.25.21262601 — Posted: 2021-08-31
Apropos of Universal Epitope Discovery for COVID-19 Vaccines: A Framework for Targeted Phage Display-Based Delivery and Integration of New Evaluation Tools
Markosian, C., Staquicini, D. I., Dogra, P., Dodero-Rojas, E., Tang, F. H. F., Smith, T. L., Contessoto, V. G., Libutti, S. K., Wang, Z., Cristini, V., Whitford, P. C., Burley, S. K., Onuchic, J. N., Pasqualini, R., Arap, W.
10.1101/2021.08.30.458222 — Posted: 2021-08-31
Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge
Hilligan, K. L., Namasivayam, S., Clancy, C. S., O'Mard, D., Oland, S. D., Robertson, S. J., Baker, P. J., Castro, E., Garza, N. L., Lafont, B. A. P., Johnson, R., Ronchese, F., Mayer-Barber, K. D., Best, S. M., Sher, A.
10.1101/2021.08.30.458273 — Posted: 2021-08-31
Strikingly different roles of SARS-CoV-2 fusion peptides uncovered by neutron scattering
Santamaria, A., Batchu, K. C., Matsarskaia, O., Prevost, S. F., Russo, D., Natali, F., Seydel, T., Hoffmann, I., Laux, V., Haertlein, M., Darwish, T. A., Russell, R. A., Corucci, G., Fragneto, G., Maestro, A., Zaccai, N. R.
10.1101/2021.08.30.458099 — Posted: 2021-08-31
(Machine) Learning the mutation signatures of SARS-CoV-2: a primer for predictive prognosis
Nagpal, S., Pinna, N. K., Srivastava, D., Singh, R., Mande, S. S.
10.1101/2021.08.30.458244 — Posted: 2021-08-31
Relationship between COVID-19 infection and neurodegeneration: Computational insight into interactions between the SARS-CoV-2 spike protein and the monoamine oxidase enzymes
Hok, L., Rimac, H., Mavri, J., Vianello, R.
10.1101/2021.08.30.458208 — Posted: 2021-08-31
May a Strain Chlamydia Isolated From SARS Patient's Autopsy Issues Inhibit the Proliferation of SARS-CoV? An Early Observation in Vitro.
Quan, X., Liu, W.
10.1101/2021.08.27.457969 — Posted: 2021-08-31
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
Rochman, N. D., Faure, G., Wolf, Y. I., Freddolino, P., Zhang, F., Koonin, E. V.
10.1101/2021.08.30.458225 — Posted: 2021-08-31
Inferring Transmission Fitness Advantage of SARS-CoV-2 Variants of Concern in Wastewater Using Digital PCR
Caduff, L., Dreifuss, D., Schindler, T., Devaux, A. J., Ganesanandamoorthy, P., Kull, A., Stachler, E., Fernandez-Cassi, X., Beerenwinkel, N., Kohn, T., Ort, C., Julian, T. R.
10.1101/2021.08.22.21262024 — Posted: 2021-08-31
Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria, Oxford-AstraZeneca) Vaccinations in Thai Health Care Workers
Jantarabenjakul, W., Chantasrisawad, N., Puthanakit, T., Wacharapluesadee, S., Hirankarn, N., Ruenjaiman, V., Paitoonpong, L., Suwanpimolkul, G., Torvorapanit, P., Pradit, R., Sophonphan, J., PUTCHAROEN, O.
10.1101/2021.08.27.21262721 — Posted: 2021-08-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).